[144] Lemonade, Inc. SEC Filing
The Form 144 filed for Lemonade, Inc. (LMND) reports a proposed sale of 5,000 common shares through Oppenheimer & Co. on the NYSE with an aggregate market value of $272,950. The shares were acquired on 06/07/2020 under an employee stock option plan and are to be paid in cash upon exercise on 08/13/2025. Outstanding shares are listed as 73,886,417, so the proposed sale equals roughly 0.0068% of outstanding stock. The filing also discloses three prior sales by the same person totaling 15,000 shares for $735,000 on 06/23/2025, 08/05/2025, and 08/11/2025. Signature and notice date fields are not shown in the provided content.
Il modulo 144 presentato per Lemonade, Inc. (LMND) segnala la proposta di vendita di 5.000 azioni ordinarie tramite Oppenheimer & Co. alla NYSE, per un valore di mercato complessivo di $272,950. Le azioni sono state acquistate il 06/07/2020 nell'ambito di un piano di opzioni azionarie per i dipendenti e saranno pagate in contanti al momento dell'esercizio il 08/13/2025. Le azioni in circolazione sono indicate in 73,886,417, quindi la vendita proposta corrisponde a circa il 0.0068% del capitale. La comunicazione riporta inoltre tre vendite precedenti effettuate dalla stessa persona per un totale di 15,000 azioni per $735,000 in data 06/23/2025, 08/05/2025 e 08/11/2025. I campi relativi a firma e data di notifica non sono mostrati nel contenuto fornito.
El Formulario 144 presentado para Lemonade, Inc. (LMND) informa una propuesta de venta de 5.000 acciones ordinarias a trav茅s de Oppenheimer & Co. en la NYSE, con un valor de mercado agregado de $272,950. Las acciones se adquirieron el 06/07/2020 bajo un plan de opciones sobre acciones para empleados y se pagar谩n en efectivo al ejercer el 08/13/2025. Las acciones en circulaci贸n se indican en 73,886,417, por lo que la venta propuesta equivale aproximadamente al 0.0068% del capital. La presentaci贸n tambi茅n revela tres ventas previas por la misma persona que suman 15,000 acciones por $735,000 en 06/23/2025, 08/05/2025 y 08/11/2025. Los campos de firma y fecha de notificaci贸n no aparecen en el contenido proporcionado.
Lemonade, Inc. (LMND)鞐� 雽�頃� 鞝滌稖霅� Form 144電� NYSE鞐愳劀 Oppenheimer & Co.毳� 韱淀暣 5,000 氤错喌欤�毳� 毵る弰頃� 鞓堨爼鞚措┌ 齑� 鞁滉皜齑濎暋鞚� $272,950霛缄碃 氤搓碃頃╇媹雼�. 頃措嫻 欤检嫕鞚� 06/07/2020鞐� 膦呾梾鞗� 鞀ろ啞鞓奠厴 鞝滊弰 頃橃棎 旆摑霅橃棃瓿� 08/13/2025鞐� 頄夓偓 鞁� 順勱笀鞙茧 歆�旮�霅� 鞓堨爼鞛呺媹雼�. 氚滍枆 欤检嫕靾橂姅 73,886,417鞙茧 旮办灛霅橃柎 鞛堨柎, 鞝滌晥霅� 毵る弰電� 氚滍枆欤检嫕鞚� 鞎� 0.0068%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滌棎電� 霃欖澕鞚胳澊 鞚挫爠鞐� 毵る弰頃� 齑� 15,000欤� (齑濎暋 $735,000)臧赌 06/23/2025, 08/05/2025, 08/11/2025鞐� 鞚措（鞏挫雼る姅 靷嫟霃� 瓿店皽霅橃柎 鞛堨姷雼堧嫟. 靹滊獏 氚� 韱奠鞚� 頃勲摐電� 鞝滉车霅� 雮挫毄鞐� 響滌嫓霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Le formulaire 144 d茅pos茅 pour Lemonade, Inc. (LMND) signale une proposition de vente de 5 000 actions ordinaires via Oppenheimer & Co. 脿 la NYSE, pour une valeur marchande totale de $272,950. Les actions ont 茅t茅 acquises le 06/07/2020 dans le cadre d'un plan d'options sur actions pour les employ茅s et seront pay茅es en num茅raire 脿 l'exercice le 08/13/2025. Le nombre d'actions en circulation est indiqu茅 脿 73,886,417, ainsi la vente propos茅e repr茅sente environ 0.0068% du capital. Le d茅p么t r茅v猫le 茅galement trois ventes ant茅rieures par la m锚me personne totalisant 15,000 actions pour $735,000 les 06/23/2025, 08/05/2025 et 08/11/2025. Les champs de signature et de date de notification ne figurent pas dans le contenu fourni.
Das eingereichte Formular 144 蹿眉谤 Lemonade, Inc. (LMND) meldet den geplanten Verkauf von 5.000 Stammaktien 眉ber Oppenheimer & Co. an der NYSE mit einem kumulierten Marktwert von $272,950. Die Aktien wurden am 06/07/2020 im Rahmen eines Mitarbeiter-Aktienoptionsprogramms erworben und sollen am 08/13/2025 bei Aus眉bung in Bargeld bezahlt werden. Die ausstehenden Aktien werden mit 73,886,417 angegeben, sodass der vorgeschlagene Verkauf etwa 0.0068% des ausstehenden Bestands entspricht. Die Meldung nennt au脽erdem drei fr眉here Verk盲ufe derselben Person in H枚he von insgesamt 15.000 Aktien 蹿眉谤 $735,000 am 06/23/2025, 08/05/2025 und 08/11/2025. Angaben zu Unterschrift und Mitteilungsdatum sind im bereitgestellten Inhalt nicht enthalten.
- None.
- None.
Insights
TL;DR: Routine insider option exercise and sale; transaction size is immaterial relative to outstanding shares and unlikely to move the market.
The Form 144 documents a proposed sale of 5,000 common shares valued at $272,950 via Oppenheimer on the NYSE. Relative to the 73,886,417 shares outstanding, this represents approximately 0.0068%, which is negligible for market impact. The seller also disclosed three recent sales totaling 15,000 shares for $735,000, indicating prior monetizations of option-derived holdings. The securities were acquired under an employee stock option plan and are to be paid in cash upon exercise, reducing uncertainty about payment method.
TL;DR: The filing shows compliance with Rule 144 disclosure requirements, but the provided content lacks visible signature and notice date fields.
The notice includes standard Rule 144 representations and identifies the acquisition source as the issuer via an employee stock option plan. The broker and exchange are disclosed as Oppenheimer & Co. and NYSE. However, the provided extract does not display a completed signature block or a notice date, limiting confirmation of filing completion from the content alone. Multiple recent sales by the same person are disclosed and are transparent in amount and timing.
Il modulo 144 presentato per Lemonade, Inc. (LMND) segnala la proposta di vendita di 5.000 azioni ordinarie tramite Oppenheimer & Co. alla NYSE, per un valore di mercato complessivo di $272,950. Le azioni sono state acquistate il 06/07/2020 nell'ambito di un piano di opzioni azionarie per i dipendenti e saranno pagate in contanti al momento dell'esercizio il 08/13/2025. Le azioni in circolazione sono indicate in 73,886,417, quindi la vendita proposta corrisponde a circa il 0.0068% del capitale. La comunicazione riporta inoltre tre vendite precedenti effettuate dalla stessa persona per un totale di 15,000 azioni per $735,000 in data 06/23/2025, 08/05/2025 e 08/11/2025. I campi relativi a firma e data di notifica non sono mostrati nel contenuto fornito.
El Formulario 144 presentado para Lemonade, Inc. (LMND) informa una propuesta de venta de 5.000 acciones ordinarias a trav茅s de Oppenheimer & Co. en la NYSE, con un valor de mercado agregado de $272,950. Las acciones se adquirieron el 06/07/2020 bajo un plan de opciones sobre acciones para empleados y se pagar谩n en efectivo al ejercer el 08/13/2025. Las acciones en circulaci贸n se indican en 73,886,417, por lo que la venta propuesta equivale aproximadamente al 0.0068% del capital. La presentaci贸n tambi茅n revela tres ventas previas por la misma persona que suman 15,000 acciones por $735,000 en 06/23/2025, 08/05/2025 y 08/11/2025. Los campos de firma y fecha de notificaci贸n no aparecen en el contenido proporcionado.
Lemonade, Inc. (LMND)鞐� 雽�頃� 鞝滌稖霅� Form 144電� NYSE鞐愳劀 Oppenheimer & Co.毳� 韱淀暣 5,000 氤错喌欤�毳� 毵る弰頃� 鞓堨爼鞚措┌ 齑� 鞁滉皜齑濎暋鞚� $272,950霛缄碃 氤搓碃頃╇媹雼�. 頃措嫻 欤检嫕鞚� 06/07/2020鞐� 膦呾梾鞗� 鞀ろ啞鞓奠厴 鞝滊弰 頃橃棎 旆摑霅橃棃瓿� 08/13/2025鞐� 頄夓偓 鞁� 順勱笀鞙茧 歆�旮�霅� 鞓堨爼鞛呺媹雼�. 氚滍枆 欤检嫕靾橂姅 73,886,417鞙茧 旮办灛霅橃柎 鞛堨柎, 鞝滌晥霅� 毵る弰電� 氚滍枆欤检嫕鞚� 鞎� 0.0068%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滌棎電� 霃欖澕鞚胳澊 鞚挫爠鞐� 毵る弰頃� 齑� 15,000欤� (齑濎暋 $735,000)臧赌 06/23/2025, 08/05/2025, 08/11/2025鞐� 鞚措（鞏挫雼る姅 靷嫟霃� 瓿店皽霅橃柎 鞛堨姷雼堧嫟. 靹滊獏 氚� 韱奠鞚� 頃勲摐電� 鞝滉车霅� 雮挫毄鞐� 響滌嫓霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Le formulaire 144 d茅pos茅 pour Lemonade, Inc. (LMND) signale une proposition de vente de 5 000 actions ordinaires via Oppenheimer & Co. 脿 la NYSE, pour une valeur marchande totale de $272,950. Les actions ont 茅t茅 acquises le 06/07/2020 dans le cadre d'un plan d'options sur actions pour les employ茅s et seront pay茅es en num茅raire 脿 l'exercice le 08/13/2025. Le nombre d'actions en circulation est indiqu茅 脿 73,886,417, ainsi la vente propos茅e repr茅sente environ 0.0068% du capital. Le d茅p么t r茅v猫le 茅galement trois ventes ant茅rieures par la m锚me personne totalisant 15,000 actions pour $735,000 les 06/23/2025, 08/05/2025 et 08/11/2025. Les champs de signature et de date de notification ne figurent pas dans le contenu fourni.
Das eingereichte Formular 144 蹿眉谤 Lemonade, Inc. (LMND) meldet den geplanten Verkauf von 5.000 Stammaktien 眉ber Oppenheimer & Co. an der NYSE mit einem kumulierten Marktwert von $272,950. Die Aktien wurden am 06/07/2020 im Rahmen eines Mitarbeiter-Aktienoptionsprogramms erworben und sollen am 08/13/2025 bei Aus眉bung in Bargeld bezahlt werden. Die ausstehenden Aktien werden mit 73,886,417 angegeben, sodass der vorgeschlagene Verkauf etwa 0.0068% des ausstehenden Bestands entspricht. Die Meldung nennt au脽erdem drei fr眉here Verk盲ufe derselben Person in H枚he von insgesamt 15.000 Aktien 蹿眉谤 $735,000 am 06/23/2025, 08/05/2025 und 08/11/2025. Angaben zu Unterschrift und Mitteilungsdatum sind im bereitgestellten Inhalt nicht enthalten.
FAQ
What does the LMND Form 144 disclose?
When and how were the shares being sold acquired?
How many shares has this person sold in the past three months and for how much?
What percentage of outstanding shares does the proposed sale represent?
Does the provided filing extract include the filer signature and notice date?
